IP Library Granted Patent US 7,772,276
Granted Patent B2
US 7,772,276 · App. 11/330,521 · Granted Aug 10, 2010

Exo-selective synthesis of himbacine analogs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,772,276
App. No.
11/330,521
Granted
Aug 10, 2010
Kind
B2
Abstract

This application discloses a novel process for the synthesis of himbacine analogs, as well as the compounds produced thereby. The synthesis proceeds by alternative routes including the cyclic ketal amide route, the chiral carbamate amide route, and the chiral carbamate ester route. The compounds produced thereby are useful as thrombin receptor antagonists. The chemistry disclosed herein is exemplified in the following synthesis sequence:

Claims (24)

1. A process for preparing Compound 1 via cyclization,

wherein R 2 and R 3 together form a dioxyethylene substituent and R 5 and R 6 are each independently H, unsubstituted alkyl, morpholinyl, or phenyl said cyclization comprising the steps of:

a) heating Compound 2 in a solvent to an elevated temperature; and

b) treating Compound 2 in Step “a” with a base,

wherein Compound 2 has the formula

and wherein:

R 5 , and R 6 are as defined above.

2. The process of claim 1 , wherein said solvent is selected from the group consisting of xylene, N-methylpyrrolidinone, Dimethylsulfoxide, diphenyl ether, Dimethylacetamide, and mixtures thereof.

3. The process of claim 1 , wherein the base is selected from the group consisting of organic, inorganic, and organometallic bases.

4. The process of claim 3 , wherein the base is selected from the group consisting of triethylamine, 1,5-diazabicyclo[4,3,0]non-5-ene, 1,4-diazabicyclo[2,2,2]octane, and 1,8-diazabicyclo[5,4,0]undec-7-ene.

5. The process of claim 1 , wherein said temperature is between about 70° C. and about 190° C.

6. The process of claim 1 , wherein said temperature is between about 80° C. and about 170° C.

7. The process of claim 1 , wherein said temperature is between about 100° C. and about 160° C.

8. The process of claim 1 , wherein said temperature is between about 120° C. and about 150° C.

9. A process for preparing Compound 7 via cyclization:

said cyclization comprising the steps of:

i. heating Compound 8 in a solvent to an elevated temperature; and,

ii. treating with a base,

wherein Compound 8 is given by the formula:

wherein R 15 and R 16 are each independently morpholinyl, and phenyl.

10. A process for preparing Compound 20:

comprising cyclizing Compound 21:

wherein R 10 and R 11 are each independently H or alkyl of from 1 to 6 carbon atoms, or wherein one of R 10 or R 11 is H or alkyl of from 1 to 6 carbon atoms and the other of R 10 or R 11 C(O)—R 4 wherein “R 4 ” is alkyl of from 1 to 6 carbon atoms or alkoxy of from 1 to 6 carbon atoms; and,

R 15 and R 16 are each independently —H, -unsubstituted alkyl, morpholinyl, and phenyl.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: TOPROL ACQUISITION LLC
Reel/Frame 054027/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2020
From: TOPROL ACQUISITION LLC
To: XSPIRE PHARMA, LLC
Reel/Frame 053731/0376 →
RECEIVING PARTY/ASSIGNEE ADDRESS CHANGE FOR ASSIGNMENT RECORDED AT REEL/FRAME 039767/0695 Recorded Aug 31, 2018
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 046989/0669 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046696 FRAME: 0772. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 30, 2018
From: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046988/0741 →
SECURITY INTEREST Recorded Aug 24, 2018
From: ARALEZ PHARMACEUTICAL TRADING DAC
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046696/0772 →
SECURITY INTEREST Recorded Sep 29, 2016
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PARTNERS, L.P.
Reel/Frame 039892/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 039767/0695 →
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →